510(k) device
Optilite® Freelite Mx Kappa Free Kit
The Binding Site Group , Ltd. · Kappa, Antigen, Antiserum, Control (DFH, Class II) · First FDA decision Aug 23, 2018, newest May 23, 2025Cancer detection and genomic testing
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "Optilite Freelite Mx"
MAUDE reports
0
Brand "Optilite Freelite Mx", since 2015
PubMed studies
0
Mentioning "Optilite Freelite Mx"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Optilite® Freelite Mx Kappa Free Kit
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
K250549 · Decided May 23, 2025 · 87 days after receipt
Device type: Kappa, Antigen, Antiserum, Control (DFH) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Optilite Freelite Mx", any status and sponsor, newest update first.
No registered device study names "Optilite Freelite Mx".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Optilite Freelite Mx", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DFH
63 reports: 53 malfunction, 10 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0943-2021 · Started Nov 18, 2020
Reason given: Due to customer complaints of positive bias impacting quality control. The high and low level controls are demonstrating a positive bias compared to assigned values.
Cause as FDA categorized it: Under Investigation by firm · Device type: Kappa, Antigen, Antiserum, Control (DFH)
Published research
The most relevant PubMed records for "Optilite Freelite Mx"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code DFH.
- N Latex FLC kappa, N Latex FLC lambdaSiemens Healthcare Diagnostics Products GmbH · 510(k) 2022
- Diazyme Human Kappa (k) Free Light Chain AssayDiazyme Laboratories, Inc. · 510(k) 2025
- Freelite Human Kappa and Lambda Free Diagnostic Test Kits for Use on the Roche Cobas Integra 400/400 Plus Analyzer KitThe Binding Site, Ltd. · 510(k) 2007
- FLC Kappa, FLC Lambda,FLC Control Level 1, FLC Control Level 2Sebia · 510(k) 2024
- Optilite® Freelite® Kappa Free Kit, Optilite® Freelite® Lambda Free KitThe Binding Site, Ltd. · 510(k) 2024
- Optilite FreeLite Kappa Free Kit, Optilite Freelite Lambda Free KitThe Binding Site Group , Ltd. · 510(k) 2015
- Human Kappa and Lambda Free Kitfor Use on the Spa Plus AnalyserThe Binding Site Group , Ltd. · 510(k) 2013
- Kappa Light ChainsSENTINEL CH. SpA · 510(k) 2009
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.